Sunil Healthcare Limited Share Price

Equities

SUNLOC6

INE671C01016

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:53 26/04/2024 BST 5-day change 1st Jan Change
84.47 INR +5.00% Intraday chart for Sunil Healthcare Limited +27.60% +54.11%

Financials

Sales 2022 1.19B 14.3M 1.14B Sales 2023 1.1B 13.26M 1.06B Capitalization 585M 7.02M 560M
Net income 2022 64M 768K 61.33M Net income 2023 66M 792K 63.25M EV / Sales 2022 0.9 x
Net Debt 2022 344M 4.13M 330M Net Debt 2023 341M 4.09M 327M EV / Sales 2023 0.84 x
P/E ratio 2022
11.4 x
P/E ratio 2023
8.75 x
Employees 221
Yield 2022 *
-
Yield 2023
-
Free-Float 14.99%
More Fundamentals * Assessed data
Dynamic Chart
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
CARE Lowers Rating on Sunil Healthcare's Long-term Bank Financing to BBB-; Revises Outlook to Negative MT
Sunil Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
CARE Affirms BBB Rating on Sunil Healthcare's Long-Term Bank Financing; Revises Outlook to Negative MT
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sunil Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Sunil Healthcare Limited Announces Company Secretary and Compliance Officer Changes CI
Sunil Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Sunil Healthcare Limited Announces Change in Designation of Sanjay Kumar Kaushik from Independent Director to Non-Executive Director CI
Sunil Healthcare Limited Announces Resignation of Santosh Kumar Sharma as Company Secretary & Compliance Officer CI
Sunil Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
CARE Improves Rating Rating on Sunil Healthcare's Bank Financing to BBB; Outlook Stable MT
Sunil Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
More news
1 day+5.00%
1 week+27.60%
Current month+37.13%
1 month+37.13%
3 months+11.16%
6 months+62.44%
Current year+54.11%
More quotes
1 week
69.00
Extreme 69
84.47
1 month
58.55
Extreme 58.55
84.47
Current year
56.50
Extreme 56.5
84.47
1 year
45.65
Extreme 45.65
84.47
3 years
29.30
Extreme 29.3
172.70
5 years
13.80
Extreme 13.8
172.70
10 years
13.80
Extreme 13.8
172.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 28/06/10
Director of Finance/CFO 51 31/10/11
Chief Administrative Officer 48 11/12/11
Members of the board TitleAgeSince
Chief Executive Officer 68 28/06/10
Director/Board Member 55 02/06/03
Director/Board Member 72 10/11/16
More insiders
Date Price Change Volume
26/04/24 84.47 +5.00% 4,888
25/04/24 80.45 +5.00% 11,944
24/04/24 76.62 +4.99% 6,196
23/04/24 72.98 +4.99% 6,852
22/04/24 69.51 +5.00% 8,658

Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am

More quotes
Sunil Healthcare Limited is an India-based company that is engaged in manufacturing hard shell capsules. The Company manufactures empty hard gelatin, HPMC capsule shells and ayurvedic medicines. Its products are categorized based on their type, specifications and customization. The Company offers various capsules, including BSE/TSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, Flavored Capsules, SLS Free Capsules, Natural Color Capsules, Non-Azo Capsules and Preservative Free Capsules. Its hard gelatin capsule shells are available in nine sizes, such as 00, 0SEL, 0EL, 0,1,2,3, 4, 5. Its ayurvedic products include haldi extract, ginger extract, vasaka extract and salaki extract and others. The vegetable capsules are commonly used as an option to gelatin because of its vegetarian source and its physical appearance to gelatin. Stick Free Capsules are used to deliver medicament to the human lungs. The Company has manufacturing plant in Alwar (Rajasthan), India.
More about the company
  1. Stock Market
  2. Equities
  3. SUNLOC6 Stock